MENU
GBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Generation Bio (GBIO) Ownership - Who owns Generation Bio?

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases... Show more

Profile

Industry
N/A
Address
301 Binney Street
Phone
+1 617 655-7500
Employees
174
Web
https://www.generationbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.66M
P/E Ratio
N/A
Total Cash
157.56M
Projected Growth
N/A
Total Debt
87.58M
Revenue
24.56M
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash/Share
2.35
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price

Fundamentals

GBIO
Capitalization
25.7M
P/E Ratio
N/A
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash
158M
Total Cash/Share
2.35
Total Debt
87.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
24.6M
ROE
N/A
Book Value
73.3M
P/B Ratio
0.35
Cash Flow
N/A
Earnings
-1.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
8.43
Current Revenue Per Employee
75852.17
Dividends Per Share - Security
N/A
EBITDA
-69.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.53
Shares Held By Institutions
105M
Shares Outstanding - Current
67M
Total Liabilities
128M
Total Volume MTD
N/A
Value
-1
Gain YTD
-62.953
View a ticker or compare two or three
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
301 Binney Street
Phone
+1 617 655-7500
Employees
174
Web
https://www.generationbio.com